Perceptive Informatics Strengthens Cardiac Capabilities
Perceptive Informatics (Boston, MA) is expanding its imaging capabilities for cardiology trials with the addition of nuclear imaging technology from Hermes Medical Solutions (Stockholm, Sweden) and INVIA (Ann Arbor, MI).
"Key goals in expanding our capabilities with this advanced nuclear imaging functionality are to help customers make earlier safety and efficacy assessments and better decisions about their compounds in order to bring new cardiovascular treatments to patients sooner,” said Kenneth G. Faulkner, PhD, Perceptive's Vice President of Medical Imaging, in a press release.
By incorporating components of Hermes Medical Solutions' Nuclear Medicine Software Suite and INVIA's Corridor4DM, Perceptive says it will enhance the electronic processing, review, analysis, reporting, and archiving of images for cardiology trials.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
